Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.46%||171.99||0.7%||$974.20m|
|LLY||Eli Lilly & Co.||0.27%||302.11||1.1%||$748.15m|
|MRK||Merck & Co., Inc.||0.36%||87.51||0.7%||$740.74m|
|BMY||Bristol-Myers Squibb Co.||-0.25%||71.94||1.0%||$648.20m|
|SIGA||SIGA Technologies, Inc.||3.35%||24.08||0.0%||$426.68m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-2.52%||213.08||8.1%||$235.19m|
|HZNP||Horizon Therapeutics Plc||0.06%||69.64||5.4%||$197.90m|
|NVO||Novo Nordisk A/S||-0.49%||102.71||0.1%||$152.17m|
Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.